141 related articles for article (PubMed ID: 9305380)
21. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
22. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
23. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
24. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of thin-layer cytology in patients undergoing cervical cone biopsy.
Bergeron C; Bishop J; Lemarie A; Cas F; Ayivi J; Huynh B; Barrasso R
Acta Cytol; 2001; 45(4):519-24. PubMed ID: 11480712
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
27. Diagnoses and outcomes in cervical cancer screening: a population-based study.
Insinga RP; Glass AG; Rush BB
Am J Obstet Gynecol; 2004 Jul; 191(1):105-13. PubMed ID: 15295350
[TBL] [Abstract][Full Text] [Related]
28. Adequacy of screening cervical cytology among human immunodeficiency virus-seropositive women.
Spinillo A; Capuzzo E; Tenti P; De Santolo A; Piazzi G; Iasci A
Gynecol Oncol; 1998 May; 69(2):109-13. PubMed ID: 9600816
[TBL] [Abstract][Full Text] [Related]
29. Are benign cellular changes on a Papanicolaou smear really benign? A prospective cohort study.
Margolis KL; Carson LF; Setness PA; Stanley MW; Henry-Stanley MJ; Beneke J; Linzie B; McGlennen RC
Arch Fam Med; 1999; 8(5):433-9. PubMed ID: 10500518
[TBL] [Abstract][Full Text] [Related]
30. [Value of acetic acid smear test for cervical cancer screening].
Wu LY; Li N; Zhang WH; Li L; Pan QJ; Qiao YL; Rong SD; Zhao FH; Pretorius RG; Belinson JL
Ai Zheng; 2003 Oct; 22(10):1096-8. PubMed ID: 14558960
[TBL] [Abstract][Full Text] [Related]
31. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme.
Nygård JF; Sauer T; Nygård M; Skare GB; Thoresen SØ
J Med Screen; 2004; 11(2):70-6. PubMed ID: 15153321
[TBL] [Abstract][Full Text] [Related]
32. Less medical intervention after sharp demarcation of Grade 1-2 cervical intraepithelial neoplasia smears by neural network screening.
Kok MR; Boon ME; Schreiner-Kok PG; Hermans J; Grobbee DE; Kok LP
Cancer; 2001 Jun; 93(3):173-8. PubMed ID: 11391604
[TBL] [Abstract][Full Text] [Related]
33. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears.
Rozendaal L; Walboomers JM; van der Linden JC; Voorhorst FJ; Kenemans P; Helmerhorst TJ; van Ballegooijen M; Meijer CJ
Int J Cancer; 1996 Dec; 68(6):766-9. PubMed ID: 8980181
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the 5-year review of negative cervical smears in patients with high grade squamous intraepithelial lesions.
Tabbara SO; Sidawy MK
Diagn Cytopathol; 1996 Jul; 15(1):7-10; discussion 10-1. PubMed ID: 8807245
[TBL] [Abstract][Full Text] [Related]
35. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
[TBL] [Abstract][Full Text] [Related]
36. Cytologic predictors of cervical intraepithelial neoplasia in women with an ASCUS Pap smear.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
Acta Cytol; 2000; 44(4):576-86. PubMed ID: 10934951
[TBL] [Abstract][Full Text] [Related]
37. Screening for cervical cancer: experience from the Colposcopy Clinic at Harare Hospital.
Chirenje ZM; Akino V
Cent Afr J Med; 1993 Nov; 39(11):222-4. PubMed ID: 8055551
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL.
Ferris DG; Wright TC; Litaker MS; Richart RM; Lorincz AT; Sun XW; Woodward L
J Fam Pract; 1998 Feb; 46(2):136-41. PubMed ID: 9487319
[TBL] [Abstract][Full Text] [Related]
39. The inadequate smear: does it matter?
Bhaumik J; Morris PG; Beer HR; Fielder H; Coles EC; Leeson S
Cytopathology; 2004 Oct; 15(5):271-5. PubMed ID: 15456415
[TBL] [Abstract][Full Text] [Related]
40. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
